| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.TEM.2006.07.007 |
| P698 | PubMed publication ID | 16890450 |
| P2093 | author name string | Hélène De Leersnyder | |
| P433 | issue | 7 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | melatonin | Q180912 |
| Smith-Magenis syndrome | Q2295338 | ||
| P304 | page(s) | 291-8 | |
| P577 | publication date | 2006-09-01 | |
| P1433 | published in | Trends in Endocrinology and Metabolism | Q15265727 |
| P1476 | title | Inverted rhythm of melatonin secretion in Smith-Magenis syndrome: from symptoms to treatment | |
| P478 | volume | 17 |
| Q41720015 | Aberrant Proteostasis of BMAL1 Underlies Circadian Abnormalities in a Paradigmatic mTOR-opathy |
| Q84523904 | Abnormal circadian rhythm of melatonin in Smith-Magenis syndrome patients with RAI1 point mutations |
| Q36027440 | Behavioral disturbance and treatment strategies in Smith-Magenis syndrome |
| Q48393217 | Behavioral phenotype in the 9q subtelomeric deletion syndrome: a report about two adult patients |
| Q47920013 | Characterization of human pineal gland proteome |
| Q38271292 | Current Phase II investigational therapies for insomnia |
| Q48114792 | Dermatologic features of Smith-Magenis syndrome |
| Q57093582 | Dynamics in enzymatic protein complexes offer a novel principle for the regulation of melatonin synthesis in the human pineal gland |
| Q57062003 | Early adolescent Rai1 reactivation reverses transcriptional and social interaction deficits in a mouse model of Smith-Magenis syndrome |
| Q40947400 | First Case Report of Smith-Magenis Syndrome (SMS) Among the Arab Community in Nazareth: View and Overview |
| Q37735169 | Investigational melatonin receptor agonists |
| Q50418448 | Low maternal melatonin level increases autism spectrum disorder risk in children |
| Q51619971 | Molecular dynamics and social regulation of context-dependent plasticity in the circadian clockwork of the honey bee. |
| Q58914961 | Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction |
| Q28078189 | Neurodevelopmental Disorders Associated with Abnormal Gene Dosage: Smith-Magenis and Potocki-Lupski Syndromes |
| Q37235719 | New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists |
| Q47557441 | New perspectives on the role of melatonin in human sleep, circadian rhythms and their regulation |
| Q91953477 | Pediatric Prolonged-Release Melatonin for Sleep in Children with Autism Spectrum Disorder: Impact on Child Behavior and Caregiver's Quality of Life |
| Q27322785 | Phenotypic consequences of copy number variation: insights from Smith-Magenis and Potocki-Lupski syndrome mouse models |
| Q37552532 | Physiology and pharmacology of melatonin in relation to biological rhythms |
| Q38380119 | Pineal gland expression of the transcription factor Egr-1 is restricted to a population of glia that are distinct from nestin-immunoreactive cells |
| Q54941417 | Precision Light for the Treatment of Psychiatric Disorders. |
| Q22306021 | Prolonged-release formulation of melatonin (Circadin) for the treatment of insomnia |
| Q33779025 | Rai1 frees mice from the repression of active wake behaviors by light. |
| Q37004418 | Role of the melatonin system in the control of sleep: therapeutic implications |
| Q38806294 | Sleep Complaints and the 24-h Melatonin Level in Individuals with Smith-Magenis Syndrome: Assessment for Effective Intervention. |
| Q91794197 | Sleep as a translationally-relevant endpoint in studies of autism spectrum disorder (ASD) |
| Q92083253 | Smith-Magenis Syndrome: Molecular Basis of a Genetic-Driven Melatonin Circadian Secretion Disorder |
| Q24320361 | Smith-Magenis syndrome results in disruption of CLOCK gene transcription and reveals an integral role for RAI1 in the maintenance of circadian rhythmicity |
| Q93050878 | Transcriptome Analysis of Pineal Glands in the Mouse Model of Alzheimer's Disease |
Search more.